Intelligence Platform
Patents
Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6998252
Recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulato
expired patentUS 6991793
Method of protecting fish against columnaris disease with modified live Flavobacterium col
expired patentUS 6989370
Bacteriocins and novel bacterial strains
expired patentUS 6987096
Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
expired patentUS 6987125
Compositions and methods of treating, reducing and preventing cardiovascular diseases and
expired patentUS 6984379
Gene therapy by administration of genetically engineered CD34+ cells obtained from cord bl
expired patentUS 6984504
Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus replicons
expired patentUS 6984388
Adhesion deficient isolate of Flavobacterium columnare against columnaris disease
expired patentUS 6984381
Vaccine for the prevention of bacterial infection of the bovine mammary gland
expired patentUS 6982168
Immortal human prostate epithelial cell lines and clones and their applications in the res
expired patentUS 6979724
Calcium channel proteins
expired patentUS 6977245
Oligodeoxynucleotide and its use to induce an immune response
expired patentUS 6977241
SH2 domain binding inhibitors
expired patentUS 6974698
Methods for delivering biologically active molecules into cells
expired patentUS 6969602
Production of an immunovariant strain of Eimeria maxima contributes to strain cross-protec
expired patentUS 6969609
Recombinant vector expressing multiple costimulatory molecules and uses thereof
expired patentUS 6965017
Melanoma antigens and their use in diagnostic and therapeutic methods
expired patentUS 6965022
Methods to identify swine genetically resistant to F18 E. coli associated diseases
expired patentUS 6963769
Method for enhancing contrast produced by MRI
expired patentUS 6962987
Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte binding protei
expired patentUS 6958319
Formulation of boronic acid compounds
expired patentUS 6955895
Thymic stromal lymphopoietin receptor molecules and uses thereof
expired patentUS 6951917
MHC-class II restricted melanoma antigens and their use in therapeutic methods
expired patentUS 6951915
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target
expired